Try our Advanced Search for more refined results
Intellectual Property
-
February 18, 2026
Axsome Blocks Sleep Disorder Drug Generic Until 2040
Biopharmaceutical business Axsome Therapeutics Inc. has inked a deal to end lawsuits against Alkem Laboratories Ltd. over its generic version of a multimillion-dollar drug meant to help people with excessive daytime sleepiness, keeping the generic off the market for years.
-
February 18, 2026
This Firm Nabbed The Top Spot In Patent Activity Rankings
The law firm that secured the most utility patents in 2025, with 5,242 patents, retained the lead from 2024, although it experienced a slight dip in activity, according to a new report from Harrity Patent Analytics.
-
February 18, 2026
BMW Rips Onesta's Claim That Qualcomm Deal Ends Patent Row
Onesta IP has told the Federal Circuit that it reached a deal with Qualcomm that resolves its controversial patent suits against BMW in Germany over U.S. patents, but BMW fired back that Onesta doesn't have "any shred of evidence to back its grandiose assertions."
-
February 18, 2026
Amazon Says Atty Accused Of TM Scheme Used AI Citations
Amazon has told a Seattle federal judge that California attorney Kathy Q. Hao relied on artificial intelligence-hallucinated case law in her effort to escape its lawsuit accusing her of participating in a fraudulent trademark scheme, urging the court to weigh sanctions against the lawyer over what the e-commerce and technology giant called "fabricated citations."
-
February 18, 2026
Will Jurors Penalize AI? Study Examines Trade Secrets Impact
A forthcoming academic study suggests juries may treat AI-enabled actions more harshly than human conduct in trade secrets disputes, resulting in what the authors call an “AI penalty.” Attorneys say reality is more complicated.
-
February 18, 2026
Judge Won't Let Slacker CEO Out Of Sony's Royalties Suit
A New York federal judge has declined to let the CEO of music streaming companies Slacker and LiveOne out of a suit brought by Sony Music Entertainment over allegations of unpaid royalties, saying that while some of Sony's claims are a bit general, they are good enough at this stage of the case.
-
February 18, 2026
PTAB Axes Showerhead Patent After Squires-Ordered Do-Over
A split Patent Trial and Appeal Board on Wednesday found that all of the claims in a Delta Faucet patent for a light on a showerhead were invalid, after the head of the U.S. Patent and Trademark Office told the board to take another look at Kohler's challenge to the patent.
-
February 18, 2026
Ericsson Asks Court To Preempt Acer Suits Over 4G, 5G Patents
Ericsson Inc. is asking a Delaware federal court for a ruling that it hasn't infringed six patents owned by Acer Inc. covering 4G, LTE and 5G wireless standards, filing its suit shortly after Acer went after Ericsson customers in a separate action.
-
February 18, 2026
USPTO Making Moves To Handle Surge In Reexam Requests
The U.S. Patent and Trademark Office has seen a sizable increase in requests for ex parte reexaminations of patents and has launched efforts to effectively manage them, and placed conditions on anonymous requests, officials said Wednesday.
-
February 18, 2026
Senators Push For Transparency In Litigation Funding
Lawmakers are trying again to rein in third-party litigation financing, a multibillion-dollar industry that critics argue allows foreign entities to assert control of the U.S. legal system.
-
February 18, 2026
Texas A&M Employee Dodges '12th Man' Copyright Suit
A Texas federal judge has dismissed copyright infringement claims against a Texas A&M University athletics communications employee who was accused of posting part of a book online related to the school's "12th Man" tradition, saying he's immune from such claims as an employee of the state.
-
February 18, 2026
9th Circ. Affirms Tracy Anderson's Workout Copyright Loss
The Ninth Circuit on Tuesday affirmed a ruling that invalidated copyrights to celebrity fitness trainer Tracy Anderson's "Tracy Anderson Method" workout routines in 19 DVDs, finding that the routines are unprotectable methods designed to improve health, similar to yoga poses at issue in the Ninth Circuit's Bikram ruling.
-
February 18, 2026
Fed. Circ. Backs More Samsung PTAB Wins Over Audio Tech
The Federal Circuit on Wednesday backed most of the Patent Trial and Appeal Board's decisions to invalidate claims in a duo of earpiece technology patents challenged by Samsung, though it agreed to revive two claims the electronics giant didn't ask the board to ax.
-
February 18, 2026
Texas Co. Accuses Asian Firms Of Memory Tech Infringement
A Japanese company and a South Korean company are importing memory chips into the U.S. that infringe on eight patents held by a Texas-based technology research firm, the firm told the U.S. International Trade Commission in a complaint.
-
February 18, 2026
Morgan Lewis Adds Fenwick Litigator Duo In LA, Seattle
Morgan Lewis & Bockius LLP continues boosting its West Coast litigation team, announcing Wednesday it is bringing in a pair of Fenwick & West LLP trial attorneys as partners in its Los Angeles and Seattle offices.
-
February 17, 2026
Trade Secrets Expert Defends Patent Review In $1M Tech Row
Counsel for an audio-video network transmission company on Tuesday pressed an aerospace manufacturer's trade secrets expert on why he reviewed only select portions of a disputed AVoIP patent, setting up the first of a three-day bench trial over a soured $1 million technology deal.
-
February 17, 2026
Judge Trims Moderna's Defenses In COVID Patent Suit
A federal judge sitting in Delaware on Tuesday ruled that Moderna could not use obviousness to defend itself from patent claims brought by a rival vaccine developer since it already used that as a defense in related Patent Trial and Review Board proceedings, saying that Moderna had offered expert opinions to support a defense that the patents don't sufficiently teach about the claimed invention.
-
February 17, 2026
Betting Tech Rivals Settle Antitrust, Patent Row
Sports technology company Panda Interactive has settled its patent dispute with its rival Sportradar and asked a Texas federal judge to stay all activity in the case for 30 days while the parties finalize the agreement.
-
February 17, 2026
Flat Fee Or Contingency? Firm, Ex-Client Fight Over IP Spoils
A 3D printing technology company has urged a Washington federal court to toss a breach of contract lawsuit brought by its former law firm, Lee & Hayes PC, arguing it agreed to a flat fee ahead of a patent settlement, while Lee & Hayes says it only waived a contingency fee because of its onetime client's "underhanded misrepresentations."
-
February 17, 2026
Fed. Circ. Greenlights $71M Christmas Tree Patent Verdict
The Federal Circuit on Tuesday affirmed a $71.4 million judgment against Polygroup Ltd. for infringing rival Willis Electric Co. Ltd.'s artificial prelit Christmas tree patent, rejecting Polygroup's arguments that the patent was invalid and Willis' damages expert should have been excluded.
-
February 17, 2026
Post U May Be Owed Billions In IP Damages, Jury Told
The company behind academic file sharing website Course Hero could owe Post University billions of dollars in damages for infringing the copyrights of nearly 2,200 learning documents, a federal jury in Hartford, Connecticut, heard Tuesday during opening statements in a trial five years in the making.
-
February 17, 2026
CoStar Rival Urges High Court To Reject Antitrust Appeal
A rival accusing CoStar of blocking competition for commercial real estate listing services is urging the U.S. Supreme Court not to review a ruling that revived the rival's counterclaims, saying that CoStar just disagrees with how the appeals court viewed the allegations.
-
February 17, 2026
OpenAI's Video App Can't Use 'Cameo' As TM Case Proceeds
A California federal judge issued a preliminary injunction blocking OpenAI from using the word "Cameo" to refer to a component of its Sora AI video generator app in litigation brought by a personalized video provider of the same name, which argued that its consumer reputation was threatened by the artificial intelligence company.
-
February 17, 2026
Valve Jury Says Rothschild, Atty Broke Anti-Patent Troll Law
Inventor Leigh Rothschild, his companies and his former attorney broke Washington state's anti-patent trolling law by making a bad faith assertion of patent infringement against video game developer Valve Corp., and Rothschild and his companies breached an intellectual property licensing deal in the process, a Seattle federal jury found on Tuesday.
-
February 17, 2026
Squires Ends IPR After ITC Judge Rejects Validity Challenge
U.S. Patent and Trademark Office Director John Squires ended a Patent Trial and Appeal Board review of a Hydrafacial LLC skin treatment patent since the same issue had already been adjudicated in the U.S. International Trade Commission.
Expert Analysis
-
Trade Secret Steps To Take As Exposure Risk Increases
Against the backdrop of rising trade secret litigation, greater employee mobility and constraints on noncompetes, recent cases highlight the importance of minimizing trade secret risks when employees leave or when new hires join, say attorneys at Sullivan & Cromwell.
-
Open Questions After Defense Contractor Executive Order
The scope and long-term effects of President Donald Trump’s executive order on the U.S. defense industrial base are uncertain, but the immediate impact is significant as it appears to direct the U.S. Department of Defense to take a more active role in contractor affairs, say attorneys at Morgan Lewis.
-
What Artists Can Learn From Latest AI Music Licensing Deals
Recent partnerships between music labels and artificial intelligence companies raise a number of key questions for artists, rightsholders and other industry players about IP, revenue-sharing, and rights and obligations, say attorneys at Manatt.
-
If Your AI Vendor Goes Bankrupt: Keeping Licensed IP Access
With contracting norms still evolving to account for the licensing of artificial intelligence tools, customers that need to retain access to key AI products in the event of vendor’s bankruptcy should consider four elements that could determine whether they may invoke traditional Section 365(n) intellectual property protections, say attorneys at Sidley.
-
USPTO's New Patentability Focus Helps Emerging Tech
The U.S. Patent and Trademark Office's recent efforts to shift patentability criteria back toward traditional standards of novelty, obviousness and adequate disclosure should make it easier for emerging tech, including artificial intelligence, to obtain patents, says Bill Braunlin at Barclay Damon.
-
Malpractice Claim Assignability Continues To Divide Courts
Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.
-
Tips For Financial Advisers Facing TRO From Former Firm
The Eighth Circuit's recent decision in Choreo v. Lors, overturning a lower court's sweeping injunction after financial advisers moved to a new firm, gives advisers new strategies to fight restraining orders from their old firms, such as focusing on whether the alleged irreparable harm is calculable, say attorneys at Kutak Rock.
-
Learning From A Typical Section 1782 Discovery Case
A California federal judge's recent approval of a Section 1782 application, compelling a U.S.-based company to produce materials relevant to a German patent dispute, usefully illustrates the specific steps foreign litigants must undertake before wielding this powerful tool for obtaining evidence unavailable via discovery mechanisms abroad, say attorneys at Fish & Richardson.
-
How To Trademark A Guy In 8 Ways: An IP Strategy Against AI
Attempting a novel method of protection against artificial intelligence misuse of his voice and likeness, Matthew McConaughey's recent efforts to register eight trademarks for a series of audio and video clips of himself underscore the importance of extending existing legal frameworks beyond traditional applications, says Summer Todd at Patterson Intellectual Property.
-
Utilizing The ITC To Combat 'Gray Market' IP Infringement
As technological developments intensify trademark owners' need to respond swiftly to "gray market" sales of international goods imported into the U.S. without the trademark owner's consent, litigating at the U.S. International Trade Commission offers an underutilized enforcement option, say attorneys at MoFo.
-
Series
Teaching Logic Makes Me A Better Lawyer
Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.
-
From IPR To EPR: The Rapid Rise Of Ex Parte Reexamination
With the current administration's dramatic shifts in policy rendering inter partes reviews essentially unavailable for the majority of patents being asserted in litigation, IPR filing rates have plunged, and ex parte reexamination requests have surged to the average rate of IPR petitions in 2024, say attorneys at McKool Smith.
-
Series
Law School's Missed Lessons: Practicing Resilience
Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.
-
Upshot Of 'Skinny Label' Case May Go Beyond Pharma
The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," carries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.
-
Assessing Factors Behind Biosimilar Uptake And Competition
As biosimilar uptake remains uneven and questions linger over whether the Biologics Price Competition and Innovation Act can deliver robust competition between biologics and biosimilars, a case study of Humira and its biosimilars illustrates how many factors, including payor reimbursement and formulary strategy, collectively shape competitive dynamics, say analysts at Analysis Group.